CFP
Basic information
Region (hg38): X:47623172-47630305
Previous symbols: [ "PFC" ]
Links
Phenotypes
GenCC
Source:
- properdin deficiency, X-linked (Supportive), mode of inheritance: XL
- properdin deficiency, X-linked (Strong), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Properdin deficiency, X-linked | XL | Allergy/Immunology/Infectious | Individuals are especially susceptible to Neisseria infections, warranting infectious prophylaxis and early and aggressive treatment of infections | Allergy/Immunology/Infectious | 8530058; 8871668; 10909851; 22229731 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CFP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 42 | 48 | ||||
missense | 75 | 85 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 3 | 2 | 1 | 6 | ||
non coding | 20 | 25 | ||||
Total | 1 | 2 | 82 | 66 | 11 |
Variants in CFP
This is a list of pathogenic ClinVar variants found in the CFP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-47624273-T-A | CFP-related disorder | Benign (Jul 11, 2019) | ||
X-47624278-G-C | Likely benign (Jun 27, 2022) | |||
X-47624311-C-T | Likely benign (Jan 08, 2024) | |||
X-47624316-G-A | Uncertain significance (Dec 07, 2023) | |||
X-47624325-G-A | Inborn genetic diseases | Uncertain significance (Jan 17, 2024) | ||
X-47624325-G-C | CFP-related disorder | Uncertain significance (Jul 10, 2023) | ||
X-47624337-C-T | Uncertain significance (Nov 23, 2021) | |||
X-47624342-A-G | Uncertain significance (Feb 04, 2023) | |||
X-47624353-C-A | Benign (Nov 13, 2023) | |||
X-47624353-C-T | Likely benign (Aug 24, 2022) | |||
X-47624356-T-C | Likely benign (Apr 07, 2022) | |||
X-47624361-G-A | Likely benign (Jan 08, 2023) | |||
X-47624365-C-T | Uncertain significance (Aug 22, 2021) | |||
X-47624372-C-T | Uncertain significance (Jul 07, 2023) | |||
X-47624376-G-T | Uncertain significance (Jun 13, 2022) | |||
X-47624384-C-G | Uncertain significance (Dec 21, 2021) | |||
X-47624384-C-T | Uncertain significance (Dec 07, 2022) | |||
X-47624394-A-C | Inborn genetic diseases | Uncertain significance (Aug 22, 2023) | ||
X-47624401-G-A | not specified | Benign (Feb 01, 2024) | ||
X-47624449-T-TTAGGGGTGGGGAGGAACGGAAGGGAGAATCTCAGGGAAGGCAAGAATGCATTCAATTCTTATTGAGTGCCTCAGGCCC | Uncertain significance (Oct 11, 2023) | |||
X-47624450-TA-T | Likely benign (Aug 23, 2023) | |||
X-47624454-G-A | Likely benign (Sep 01, 2023) | |||
X-47626039-A-G | Likely benign (Feb 11, 2022) | |||
X-47626045-C-T | Likely benign (Oct 25, 2023) | |||
X-47626057-C-T | Uncertain significance (Feb 12, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CFP | protein_coding | protein_coding | ENST00000247153 | 9 | 6093 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.688 | 0.312 | 125592 | 3 | 1 | 125596 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.17 | 115 | 202 | 0.571 | 0.0000173 | 2952 |
Missense in Polyphen | 36 | 84.21 | 0.4275 | 1144 | ||
Synonymous | 0.988 | 68 | 79.2 | 0.859 | 0.00000666 | 931 |
Loss of Function | 3.47 | 4 | 21.3 | 0.188 | 0.00000172 | 286 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000495 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: A positive regulator of the alternate pathway of complement. It binds to and stabilizes the C3- and C5-convertase enzyme complexes. {ECO:0000269|PubMed:20382442}.;
- Disease
- DISEASE: Properdin deficiency (PFD) [MIM:312060]: Results in higher susceptibility to bacterial infections; especially to meningococcal infections. Three phenotypes have been reported: complete deficiency (type I), incomplete deficiency (type II), and dysfunction of properdin (type III). {ECO:0000269|PubMed:10909851, ECO:0000269|PubMed:8871668, ECO:0000269|PubMed:9710744}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Herpes simplex infection - Homo sapiens (human);Human Complement System;Complement Activation;Neutrophil degranulation;alternative complement pathway;Post-translational protein modification;Metabolism of proteins;Innate Immune System;Immune System;O-glycosylation of TSR domain-containing proteins;O-linked glycosylation
(Consensus)
Recessive Scores
- pRec
- 0.268
Intolerance Scores
- loftool
- 0.330
- rvis_EVS
- 0.35
- rvis_percentile_EVS
- 74.37
Haploinsufficiency Scores
- pHI
- 0.145
- hipred
- Y
- hipred_score
- 0.573
- ghis
- 0.442
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.662
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cfp
- Phenotype
- homeostasis/metabolism phenotype; skeleton phenotype; immune system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype;
Gene ontology
- Biological process
- proteolysis;immune response;complement activation;complement activation, alternative pathway;regulation of complement activation;defense response to bacterium;neutrophil degranulation
- Cellular component
- extracellular region;extracellular space;endoplasmic reticulum lumen;specific granule lumen;collagen-containing extracellular matrix;tertiary granule lumen
- Molecular function
- serine-type endopeptidase activity;protein binding